aldosterone and anacetrapib
aldosterone has been researched along with anacetrapib in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hegele, RA; Joy, TR | 1 |
Bloomfield, D; Briscoe, RJ; Brown, PN; Cumiskey, AM; Ehrhart, J; Forrest, MJ; Hershey, JC; Keller, WJ; Ma, X; McPherson, HE; Messina, E; Peterson, LB; Sharif-Rodriguez, W; Siegl, PK; Sinclair, PJ; Sparrow, CP; Stevenson, AS; Sun, SY; Tsai, C; Vargas, H; Walker, M; West, SH; White, V; Woltmann, RF | 1 |
Stroes, ES; Vergeer, M | 1 |
Even, S; Montezano, AC; Neves, KB; Nguyen Dinh Cat, A; Palacios, R; Rios, FJ; Touyz, RM | 1 |
Ready, JM | 1 |
Reviews
1 review(s) available for aldosterone and anacetrapib
Article | Year |
---|---|
The pharmacology and off-target effects of some cholesterol ester transfer protein inhibitors.
Topics: Aldosterone; Amides; Animals; Anticholesteremic Agents; Atherosclerosis; Blood Pressure; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Corticosterone; Esters; Humans; Hydrocortisone; Hypercholesterolemia; Oxazolidinones; Quinolines; Sulfhydryl Compounds | 2009 |
Other Studies
4 other study(ies) available for aldosterone and anacetrapib
Article | Year |
---|---|
The failure of torcetrapib: what have we learned?
Topics: Aldosterone; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Oxazolidinones; Quinolines | 2008 |
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.
Topics: Adrenal Cortex; Aldosterone; Animals; Anticholesteremic Agents; Blood Pressure; Cholesterol Ester Transfer Proteins; Corticosterone; Dogs; Drug Evaluation, Preclinical; Female; Macaca mulatta; Male; Mice; Mice, Inbred C57BL; Models, Animal; Muscle, Smooth, Vascular; Oxazolidinones; Quinolines; Rats; Rats, Sprague-Dawley; Species Specificity | 2008 |
Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes.
Topics: Adipocytes; Aldosterone; Amides; Animals; Cell Line; Cholesterol Ester Transfer Proteins; Esters; Humans; Mice; NADPH Oxidases; Oxazolidinones; Phosphorylation; Quinolines; Reactive Oxygen Species; STAT3 Transcription Factor; Sulfhydryl Compounds | 2015 |
Toward a Best-in-Class Inhibitor of Cholesteryl Ester Transfer Protein (CETP).
Topics: Aldosterone; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Drug Development; Humans; Mice, Transgenic; Molecular Structure; Oxazolidinones | 2021 |